These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20364308)

  • 1. Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene.
    Jin W; Liu Y; Chen L; Zhu H; Di GH; Ling H; Wu J; Shao ZM
    Breast Cancer Res Treat; 2011 Feb; 125(3):699-713. PubMed ID: 20364308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
    Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
    Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYB oncogene amplification in hereditary BRCA1 breast cancer.
    Kauraniemi P; Hedenfalk I; Persson K; Duggan DJ; Tanner M; Johannsson O; Olsson H; Trent JM; Isola J; Borg A
    Cancer Res; 2000 Oct; 60(19):5323-8. PubMed ID: 11034064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 is associated with the regulation of basal transcription activity of the BRCA1 gene.
    Wang Q; Li J; Yang X; Sun H; Gao S; Zhu H; Wu J; Jin W
    Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):179-87. PubMed ID: 23353771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Myb inhibits myogenic differentiation through repression of MyoD.
    Kaspar P; Pajer P; Sedlak D; Tamaoki T; Dvorak M
    Exp Cell Res; 2005 Oct; 309(2):419-28. PubMed ID: 16055116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.
    Nakuci E; Mahner S; Direnzo J; ElShamy WM
    Exp Cell Res; 2006 Oct; 312(16):3120-31. PubMed ID: 16860316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor accessibility and histone acetylation of the progesterone receptor gene differs between parental MCF-7 cells and a subline that has lost progesterone receptor expression.
    Xu X; Murdoch FE; Curran EM; Welshons WV; Fritsch MK
    Gene; 2004 Mar; 328():143-51. PubMed ID: 15019994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: a possible molecular link between stress and breast cancer.
    Antonova L; Mueller CR
    Genes Chromosomes Cancer; 2008 Apr; 47(4):341-52. PubMed ID: 18196591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 regulation of transcription.
    Rosen EM; Fan S; Ma Y
    Cancer Lett; 2006 May; 236(2):175-85. PubMed ID: 15975711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-induced down-regulation of BRCA1 expression by E2Fs.
    Bindra RS; Gibson SL; Meng A; Westermark U; Jasin M; Pierce AJ; Bristow RG; Classon MK; Glazer PM
    Cancer Res; 2005 Dec; 65(24):11597-604. PubMed ID: 16357170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
    Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
    Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).
    Williamson EA; Wolf I; O'Kelly J; Bose S; Tanosaki S; Koeffler HP
    Oncogene; 2006 Mar; 25(9):1391-9. PubMed ID: 16331276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haplo-insufficiency of BRCA1 in sporadic breast cancer.
    Staff S; Isola J; Tanner M
    Cancer Res; 2003 Aug; 63(16):4978-83. PubMed ID: 12941823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
    Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
    Chan KY; Ozçelik H; Cheung AN; Ngan HY; Khoo US
    Cancer Res; 2002 Jul; 62(14):4151-6. PubMed ID: 12124354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors.
    Joosse SA; Brandwijk KI; Mulder L; Wesseling J; Hannemann J; Nederlof PM
    Genes Chromosomes Cancer; 2011 Feb; 50(2):71-81. PubMed ID: 21104783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
    Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
    Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of MyoD and PEA3 in regulation of transcription activity of MDR1 gene.
    Zhao Y; Liu J; Hong Q; Yang C; Chen L; Chen Y; Wang Q; Zhao K; Jin W
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):900-7. PubMed ID: 20980337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.